Katina Loucaides

All filings by Katina Loucaides on record concern Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). The record holds 3 filings, all for trades on 14 March 2023.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 17 March 2023, reports a transaction in Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.